Left ventricular hypertrophy: unresolved issues.

Suppr

超能文献

作者信息

Schoenberger J A

出版信息

Curr Hypertens Rep. 1999 Aug;1(4):331-2. doi: 10.1007/s11906-999-0041-6.

DOI:10.1007/s11906-999-0041-6

PMID:10981085

Abstract

摘要

相似文献

Left ventricular hypertrophy: unresolved issues.

Curr Hypertens Rep. 1999 Aug;1(4):331-2. doi: 10.1007/s11906-999-0041-6.

Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?

J Am Coll Cardiol. 2004 Jun 16;43(12):2216-8. doi: 10.1016/j.jacc.2004.03.024.

Prognostic significance of left ventricular hypertrophy regression.

Adv Exp Med Biol. 1997;432:199-205. doi: 10.1007/978-1-4615-5385-4_22.

What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?

J Clin Hypertens (Greenwich). 2009 Aug;11(8):407-10. doi: 10.1111/j.1751-7176.2009.00156.x.

Regression of left ventricular hypertrophy.

JAMA. 1996 Aug 21;276(7):526-7. doi: 10.1001/jama.1996.03540070022017.

Regression of left ventricular hypertrophy. How and why?

JAMA. 1996 May 15;275(19):1517-8.

Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.

Blood Press Suppl. 1992;1:35-6; discussion 37.

Hypertension and left ventricular hypertrophy: what is the link?

R I Med. 1993 May;76(5):245-8.

Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy.

Adv Exp Med Biol. 1997;432:189-90. doi: 10.1007/978-1-4615-5385-4_20.

[Regression of left ventricular hypertrophy with antihypertensive therapy].

Ther Umsch. 1998 Sep;55(9):539-41.

本文引用的文献

Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

N Engl J Med. 1999 Apr 22;340(16):1221-7. doi: 10.1056/NEJM199904223401601.

Clinical trials of single-drug therapy for the cardiac effects of hypertension.

Am J Hypertens. 1999 Jan;12(1 Pt 2):12S-18S. doi: 10.1016/s0895-7061(98)00209-x.

Congestive heart failure in the community: trends in incidence and survival in a 10-year period.

Arch Intern Med. 1999 Jan 11;159(1):29-34. doi: 10.1001/archinte.159.1.29.

Prognostic significance of serial changes in left ventricular mass in essential hypertension.

Circulation. 1998;97(1):48-54. doi: 10.1161/01.cir.97.1.48.

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

JAMA. 1996 May 15;275(19):1507-13.

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment.

J Hypertens. 1995 Oct;13(10):1091-5. doi: 10.1097/00004872-199510000-00003.

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

N Engl J Med. 1993 Apr 1;328(13):914-21. doi: 10.1056/NEJM199304013281303.

Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

J Am Coll Cardiol. 1994 Nov 15;24(6):1492-8. doi: 10.1016/0735-1097(94)90145-7.

Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.

Circulation. 1994 Oct;90(4):1786-93. doi: 10.1161/01.cir.90.4.1786.

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).

Circulation. 1995 Feb 1;91(3):698-706. doi: 10.1161/01.cir.91.3.698.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验